|
Showing the most relevant articles for your search:NASDAQ:INSY 日付 | 受信時刻 | ニュースソース | 見出し | コード | 企業名 | 2019/11/04 | 20 : 08 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:INSY | Insys Therapeutics, Inc. |
2019/10/25 | 19 : 08 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:INSY | Insys Therapeutics, Inc. |
2019/10/03 | 03 : 55 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:INSY | Insys Therapeutics, Inc. |
2019/09/28 | 03 : 56 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:INSY | Insys Therapeutics, Inc. |
2019/09/26 | 19 : 07 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:INSY | Insys Therapeutics, Inc. |
2019/09/18 | 05 : 27 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:INSY | Insys Therapeutics, Inc. |
2019/09/10 | 03 : 08 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:INSY | Insys Therapeutics, Inc. |
2019/09/03 | 19 : 05 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:INSY | Insys Therapeutics, Inc. |
2019/08/30 | 05 : 31 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:INSY | Insys Therapeutics, Inc. |
2019/08/14 | 02 : 42 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:INSY | Insys Therapeutics, Inc. |
2019/08/09 | 06 : 19 | Edgar (US Regulatory) | Notification That Quarterly Report Will Be Submitted Late (nt 10-q) | NASDAQ:INSY | Insys Therapeutics, Inc. |
2019/08/09 | 06 : 10 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:INSY | Insys Therapeutics, Inc. |
2019/07/20 | 00 : 53 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:INSY | Insys Therapeutics, Inc. |
2019/07/16 | 05 : 01 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:INSY | Insys Therapeutics, Inc. |
2019/07/03 | 19 : 00 | GlobeNewswire Inc. | FDA Accepts New Drug Application for INSYS Therapeutics’ Naloxone Nasal Spray for the Emergency Treatment of Known or Suspe... | NASDAQ:INSY | Insys Therapeutics, Inc. |
2019/06/24 | 22 : 38 | Edgar (US Regulatory) | Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ... | NASDAQ:INSY | Insys Therapeutics, Inc. |
2019/06/12 | 21 : 00 | GlobeNewswire Inc. | INSYS Therapeutics, Inc. Receives Court Approval of “First Day” Motions | NASDAQ:INSY | Insys Therapeutics, Inc. |
2019/06/11 | 19 : 03 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:INSY | Insys Therapeutics, Inc. |
2019/06/10 | 22 : 32 | Dow Jones News | Stocks to Watch: Salesforce.com, Insys, United Technologies, Barnes & Noble, Dunkin' Brands, and More | NASDAQ:INSY | Insys Therapeutics, Inc. |
2019/06/10 | 20 : 19 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:INSY | Insys Therapeutics, Inc. |
2019/06/10 | 19 : 07 | GlobeNewswire Inc. | INSYS Therapeutics Initiates Court-Supervised Process to Facilitate Asset Sales and Address Legacy Liabilities | NASDAQ:INSY | Insys Therapeutics, Inc. |
2019/06/08 | 03 : 10 | Edgar (US Regulatory) | Amended Current Report Filing (8-k/a) | NASDAQ:INSY | Insys Therapeutics, Inc. |
2019/06/07 | 06 : 13 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:INSY | Insys Therapeutics, Inc. |
2019/06/07 | 06 : 11 | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | NASDAQ:INSY | Insys Therapeutics, Inc. |
2019/06/06 | 19 : 03 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:INSY | Insys Therapeutics, Inc. |
2019/06/06 | 06 : 32 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:INSY | Insys Therapeutics, Inc. |
2019/05/25 | 06 : 19 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:INSY | Insys Therapeutics, Inc. |
2019/05/13 | 19 : 09 | Edgar (US Regulatory) | Notification That Quarterly Report Will Be Submitted Late (nt 10-q) | NASDAQ:INSY | Insys Therapeutics, Inc. |
2019/05/13 | 19 : 07 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:INSY | Insys Therapeutics, Inc. |
2019/05/13 | 19 : 02 | Edgar (US Regulatory) | Quarterly Report (10-q) | NASDAQ:INSY | Insys Therapeutics, Inc. |
|
Showing the most relevant articles for your search:NASDAQ:INSY |
|